ImageneBio, Inc. (IMA)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 11, 2025 | CORRESP | Neutral/Informational | Moderate | ImageneBio, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-1, seeking to have it declared effective by September 15, 2025, … | Read Filing EDGAR |
| Sep. 11, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to ImageneBio, Inc. that they will not review the company's registration statement filed on September 8, 2025. The letter emphasizes the company's respons… | Read Filing EDGAR |
| Jun. 10, 2025 | CORRESP | Neutral/Informational | Moderate | Ikena Oncology, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-4. They are seeking to have the regist… | Read Filing EDGAR |
| Jun. 9, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Goodwin Procter to the SEC addresses comments received regarding Ikena Oncology, Inc.'s Amendment No. 4 to their Registration Statement on Form S-4. The le… | Read Filing EDGAR |
| Jun. 3, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed the amended registration statement for Ikena Oncology, Inc. and has issued comments requiring further clarification. Specifically, the SEC is seeking informat… | Read Filing EDGAR |